Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
On its own its effects are modest, but combined with GLP-1 the two create a synergistic effect that amplifies both glycemic control and fat reduction beyond what either achieves alone which is why tirzepatide generally outperforms semaglutide in head-to-head comparisons
That makes resistance exercise, or weightlifting, a must while using these medications
Retatrutide is a triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, while Zepbound (Tirzepatide) is a dual-agonist working on GLP-1 and GIP
In a 40-week Phase 3 trial, adults with type 2 diabetes taking 12 mg of retatrutide shed an average of 16.8% (36.6 lbs) of their beginning weight
US$ 22.36
US$ 24.02
US$ 24.29
US$ 23.21
US$ 21.44
US$ 20.50
US$ 24.53
US$ 24.31
US$ 29.59
US$ 26.31
